Although the roles for BIRC5 and OCT4 in cancers are well-recognized in a number of previous studies, we gave the first evidence that OCT4 indirectly manipulates the expression and function of BIRC5, and also directly upregulates the expression of CCND1. This evidence concerns the gene BIRC5 and cancer.